- June 2019 updates
We have been invited to present at the 19th annual New York Venture Summit, presented by youngStartup Ventures on July 9 and 10 at Convene New York City.
- May 2019 updates
BioNJ invited us to present at the Annual BioPartnering Conference on May 8th. The meeting was well attended by angels, seed funds, venture funds and pharma companies.
We joined Bioverge, which is an investment and engagement platform that connects startup companies to investors. Bioverge will assist us in completing our angel investment round. We were accepted into their program and they recently “Showcased” Covalent to investors in their network. The next step in their process is targeted outreach.
- April 2019 updates
Oral and poster presentation entitled “Nature-Made Catalytic Antibody Platform: From Heisenberg’s Uncertainty Principle to the Brink of Medical Interventions.” at the American Society for Biochemistry and Molecular Biology Experimental Biology Conference, April 9, 2019, Orlando.
- March 2019 updates
Covalent established an R&D lab at 7707 Fannin, suite 140, Houston TX 77054.